Polyneuropathie nach Checkpoint-Inhibitoren – eine „sarcoid-like reaction“

Publikationsverlauf

Artikel online veröffentlicht:
22. Mai 2024

• Literatur

• 1 Gkiozos I, Kopitopoulou A, Kalkanis A. et al. sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors. J Thorac Oncol 2018; 13: 1076-1082
• 2 Eljilany I, Noor A, Paravathaneni M. et al. Granulomatous and sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review. Cancers (Basel) 2023; 15: 2561
• 3 Rodriguez EF, Lipson E, Suresh K. et al. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma. Hum Pathol 2019; 91: 69-76
• 4 Prasse A. The diagnosis, differential diagnosis, and treatment of sarcoidosis. Dtsch Arztebl Int 2016; 113: 565-574
• 5 Huh JY, Moon DS, Song JW. Sarcoid-like reaction in patients with malignant tumors: Long-term clinical course and outcomes. Front Med (Lausanne) 2022; 9: 884386
• 6 Murphy KP, Kennedy MP, Barry JE. et al. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment. Oncol Res Treat 2014; 37: 351-353
• 7 Tan I, Malinzak M, Salama AKS. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy. J Immunother Cancer 2018; 6: 77